MacroGenics Inc (NASDAQ: MGNX) has reported E.P.S. of $-0.75 for its fourth fiscal quarter (ending December 31) versus $0.21 for the same period a year ago. For the latest four quarters through December 31, E.P.S. were $-0.15 compared to $-1.95 a year ago.
Recent Price Action
MacroGenics Inc (NASDAQ: MGNX) stock closed at $20.51 on 3/7/24 after a decline of -4.5%. Moreover, above average trading volume at 137% of normal accompanied the decline. Relative to the market the stock has been exceptionally strong over the last nine months and has risen 19.3% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, MGNX is expected to continue to be Value Creation neutral.
MacroGenics has a current Value Trend Rating of C (Neutral). This rating combines very contradictory signals from two proprietary PTR measures of a stock’s attractiveness. MacroGenics has a very low Appreciation Score of 3 but a very high Power Rating of 94, and the Neutral Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment